METHOD FOR TREATMENT OF NEUROECTODERMAL MALIGNANCIES AND EPITHELIAL CARCINOMAS IN HUMANS

摘要

This invention provides a use of monoclonal antibody R-24 linked to a chemotherapeutic agent for the treatment of cancer of neuroectodermal origin, epithelial cancer of pigmentation disorder and wherein the chemotherapeutic agent is at least one agent from the group dacarbazine, adriamycin, pimozide, dibromodulcitol, bleomycin, actinomycin D, purine analog, pyrimidine analog, nitrosoureas, cis-platin, radiation-emitting reagent, tumor necrosis factor, interferon, lymphotoxins, interleukin, BCG, and autologous tumor cell vaccine.